NarsisAminianMD

Clinical Trials

• Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation Start of enrollment: 2005 Aug 01

  Completed

  Phase 2

• A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair Start of enrollment: 2010 Jul 01

  Completed

  Phase 2, Phase 3

• A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) Start of enrollment: 2011 Jan 01

  Completed

  Phase 2

• Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• Riluzole in Spinal Cord Injury Study Start of enrollment: 2013 Oct 01

  Terminated

  Phase 2, Phase 3

• Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III Start of enrollment: 2013 Dec 30

  Completed

  Phase 3

• The INSPIRE Study: Probable Benefit of the Neuro-Spinal Scaffold for Treatment of AIS A Thoracic Acute Spinal Cord Injury Start of enrollment: 2014 Oct 13

  Terminated

  Not Applicable

• Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma Start of enrollment: 2015 Sep 01

  Completed

  Phase 1

• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma Start of enrollment: 2024 Dec 01

  Suspended

  Phase 3

• An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) Start of enrollment: 2016 Mar 01

  Completed

  Phase 3

• An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) Start of enrollment: 2016 May 09

  Completed

  Phase 3

• Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01

  Active, not recruiting

  Phase 3

• Join now to see all